Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice

We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural function. Vasopeptidase inhibitors block angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) activity. We propose that increased activity of ACE and NEP contrib...

Full description

Saved in:
Bibliographic Details
Main Authors: Lawrence Coppey, Bao Lu, Craig Gerard, Mark A. Yorek
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2012/326806
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549879582294016
author Lawrence Coppey
Bao Lu
Craig Gerard
Mark A. Yorek
author_facet Lawrence Coppey
Bao Lu
Craig Gerard
Mark A. Yorek
author_sort Lawrence Coppey
collection DOAJ
description We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural function. Vasopeptidase inhibitors block angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) activity. We propose that increased activity of ACE and NEP contributes to pathophysiology of DIO. To address this issue C57Bl/6J mice or mice deficient in NEP were fed a high-fat diet and treated with ilepatril, enalapril, ACE inhibitor, or candoxatril, NEP inhibitor, using both prevention and intervention protocols. Endpoints included glucose utilization and neural function determination. In the prevention study glucose tolerance was impaired in DIO C57Bl/6J mice and improved with ilepatril or enalapril. Sensory nerve conduction velocity, thermal nociception, and intraepidermal nerve fiber density were impaired in DIO C57Bl/6J mice and improved with ilepatril or candoxatril. In the intervention study only enalapril improved glucose tolerance. Sensory nerve conduction velocity and intraepidermal nerve fiber density were improved by all three treatments, whereas thermal nociception was improved by ilepatril or candoxatril. In NEP-deficient mice DIO impaired glucose utilization and this was improved with enalapril. Nerve function was not impaired by DIO in NEP-deficient mice. These studies suggest that ACE and NEP play a role in pathophysiology associated with DIO.
format Article
id doaj-art-b79eed54a96d458abbc7194abf9a66c0
institution Kabale University
issn 2090-0708
2090-0716
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-b79eed54a96d458abbc7194abf9a66c02025-02-03T06:08:22ZengWileyJournal of Obesity2090-07082090-07162012-01-01201210.1155/2012/326806326806Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J MiceLawrence Coppey0Bao Lu1Craig Gerard2Mark A. Yorek3Department of Veterans Affairs Iowa City Health Care System, Iowa City, IA 52246, USAIna Sue Perlmutter Laboratory, Children’s Hospital, Department of Pediatrics and Medicine, Harvard Medical School, Boston, MA 02115, USAIna Sue Perlmutter Laboratory, Children’s Hospital, Department of Pediatrics and Medicine, Harvard Medical School, Boston, MA 02115, USADepartment of Veterans Affairs Iowa City Health Care System, Iowa City, IA 52246, USAWe have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural function. Vasopeptidase inhibitors block angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) activity. We propose that increased activity of ACE and NEP contributes to pathophysiology of DIO. To address this issue C57Bl/6J mice or mice deficient in NEP were fed a high-fat diet and treated with ilepatril, enalapril, ACE inhibitor, or candoxatril, NEP inhibitor, using both prevention and intervention protocols. Endpoints included glucose utilization and neural function determination. In the prevention study glucose tolerance was impaired in DIO C57Bl/6J mice and improved with ilepatril or enalapril. Sensory nerve conduction velocity, thermal nociception, and intraepidermal nerve fiber density were impaired in DIO C57Bl/6J mice and improved with ilepatril or candoxatril. In the intervention study only enalapril improved glucose tolerance. Sensory nerve conduction velocity and intraepidermal nerve fiber density were improved by all three treatments, whereas thermal nociception was improved by ilepatril or candoxatril. In NEP-deficient mice DIO impaired glucose utilization and this was improved with enalapril. Nerve function was not impaired by DIO in NEP-deficient mice. These studies suggest that ACE and NEP play a role in pathophysiology associated with DIO.http://dx.doi.org/10.1155/2012/326806
spellingShingle Lawrence Coppey
Bao Lu
Craig Gerard
Mark A. Yorek
Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
Journal of Obesity
title Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
title_full Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
title_fullStr Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
title_full_unstemmed Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
title_short Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
title_sort effect of inhibition of angiotensin converting enzyme and or neutral endopeptidase on neuropathy in high fat fed c57bl 6j mice
url http://dx.doi.org/10.1155/2012/326806
work_keys_str_mv AT lawrencecoppey effectofinhibitionofangiotensinconvertingenzymeandorneutralendopeptidaseonneuropathyinhighfatfedc57bl6jmice
AT baolu effectofinhibitionofangiotensinconvertingenzymeandorneutralendopeptidaseonneuropathyinhighfatfedc57bl6jmice
AT craiggerard effectofinhibitionofangiotensinconvertingenzymeandorneutralendopeptidaseonneuropathyinhighfatfedc57bl6jmice
AT markayorek effectofinhibitionofangiotensinconvertingenzymeandorneutralendopeptidaseonneuropathyinhighfatfedc57bl6jmice